Estimating Cancer Treatment Tolerability for Older Adults With Advanced Cancer—The Holy Grail

Abstract

Estimating tolerability of cancer treatments is a continued unmet need among older adults with advanced cancer. Uncertain tolerability among older adults can lead to both undertreatment and overtreatment after a new cancer diagnosis. 1 Understanding who will experience treatment-related side effects is incredibly important, as the number of new cancer drugs is rapidly increasing, with new approvals monthly. Overall survival benefits are improving, yet gains can be modest, particularly among older adults with cancer. 2Open Access. This is an open access article distributed under the terms of the CC-BY License.